Lehdistötiedote22.08.2025 klo 11.43Notice of the Annual General Meeting of Shareholders 2025 in Eevia Health Plc
Pörssitiedote13.08.2025 klo 11.00Eevia Health: UPDATE: Eevia Warns of Continued Strained Liquidity, Delayed Audit and Write Downs
Lehdistötiedote13.06.2025 klo 09.30Eevia Health Secures c. EUR 50,000 in New Sales Orders Across Key Markets
Lehdistötiedote13.06.2025 klo 09.00Eevia Health Receives HALAL Certification, Unlocking New Market Opportunities
Pörssitiedote12.06.2025 klo 14.57Eevia Health Relocates Production to Norwegian Nutraceutical Biotechnology Hub to Drive Innovation, Avoid Investments and Cut Costs
Lehdistötiedote14.05.2025 klo 16.20Eevia Health: Eevia LAUNCHES A HIGH-STRENGTH ORGANIC ARONIA EXTRACT AT VITAFOODS 2025
Lehdistötiedote09.05.2025 klo 08.59Eevia Health: Eevia Enters Strategic North American Partnership with a KSEK 765 First Sales Order
Lehdistötiedote07.05.2025 klo 14.29Eevia Health Plc Gains Traction for Lead Pipeline Products with Two North American Industry Leaders
Lehdistötiedote06.05.2025 klo 10.45Eevia Health: Large U.S. Buyers Turn to Eevia Amid Tariff Driven Supply Chain Uncertainty